A new platform developed by researchers at the University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells, even without knowing which tumor targets are recognized by the immune cells. This approach addresses a major bottleneck in immunotherapy development and could accelerate the creation of personalized treatments.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Scientists supercharge immune cells to destroy cancer more effectively | 0 | 9.11 | 17-04-2026 |
| 2 | AI tool reveals what attracts immune cells to tumors and what keeps them away | 0 | 6.54 | 13-10-2026 |
| 3 | Antibody screening approach could speed development of immune-based cancer treatments | 0 | 14.96 | 15-10-2026 |
| 4 | Researchers identify key pathway that drives T-cell exhaustion in cancer immunotherapy | 0 | 9.07 | 15-10-2026 |
| 5 | A hidden immune backup system could supercharge mRNA cancer vaccines | 0 | 9.29 | 09-07-2026 |
| 6 | Rare stem T cells may hold the key to fighting chronic diseases | 5 | 7 | 01-07-2026 |
| 7 | Tumor on a chip reveals how pancreatic cancer hijacks immune cells in real time | 5 | 8 | 07-07-2026 |
| 8 | A Trojan horse cancer therapy shows stunning results | 0 | 7.27 | 30-01-2026 |
| 9 | Fecal microbiota transplantation may improve immunotherapy-related colitis | 0 | 9.48 | 15-09-2026 |
| 10 | Ученые нашли способ создать источник клеток для борьбы с раком | 5 | 7 | 06-07-2026 |